P277 Assessment of disease activity using RAPID3 and evaluation of treatment effect of guselkumab in patients with PsA: results from a randomised placebo-controlled Phase 2 clinical trial

Deodhar, A, Kirkham, B, Rahman, P et al. (6 more authors) (2020) P277 Assessment of disease activity using RAPID3 and evaluation of treatment effect of guselkumab in patients with PsA: results from a randomised placebo-controlled Phase 2 clinical trial. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Cancelled.

Metadata

Authors/Creators:
  • Deodhar, A
  • Kirkham, B
  • Rahman, P
  • Helliwell, P
  • Gottlieb, AB
  • Boehncke, W-H
  • Xu, XL
  • Gorecki, PC
  • Han, C
Dates:
  • Published: April 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Nov 2020 16:06
Last Modified: 06 Nov 2020 16:06
Status: Published
Identification Number: https://doi.org/10.1093/rheumatology/keaa111.270
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)